|Bid||41.77 x 800|
|Ask||42.20 x 800|
|Day's range||41.45 - 42.12|
|52-week range||26.90 - 82.35|
|Beta (5Y monthly)||1.03|
|PE ratio (TTM)||N/A|
|Earnings date||04 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||71.00|
GOLETA, Calif., October 13, 2021--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2021 financial results after market close on Thursday, November 4, 2021. The Company will host a corresponding conference call beginning at 2:00pm PT/5:00pm ET.
GOLETA, Calif., October 12, 2021--Inogen, Inc. (NASDAQ: INGN), ("Inogen" or "the Company"), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that Stanislav Glezer, MD has been appointed to the role of Chief Technology Officer responsible for R&D and Engineering, Medical Affairs, and Regulatory Affairs. Mr. Glezer will remain an Executive Vice President of the Company.
Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.